Benjamin G Mittman, Bo Hu, Rebecca Schulte, Phuc Le, Matthew A Pappas, Aaron Hamilton, Michael B Rothberg
{"title":"什么是静脉血栓栓塞症高危人群？比较确定适当阈值的方法","authors":"Benjamin G Mittman, Bo Hu, Rebecca Schulte, Phuc Le, Matthew A Pappas, Aaron Hamilton, Michael B Rothberg","doi":"10.1101/2024.08.30.24312871","DOIUrl":null,"url":null,"abstract":"<strong>Background</strong> Guidelines recommend pharmacological venous thromboembolism (VTE) prophylaxis only for high-risk patients, but the probability of VTE considered “high-risk” is not specified. Our objective was to define an appropriate probability threshold (or range) for VTE risk stratification and corresponding prophylaxis in medical inpatients.","PeriodicalId":501454,"journal":{"name":"medRxiv - Health Informatics","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What Constitutes High Risk for Venous Thromboembolism? Comparing Approaches to Determining an Appropriate Threshold\",\"authors\":\"Benjamin G Mittman, Bo Hu, Rebecca Schulte, Phuc Le, Matthew A Pappas, Aaron Hamilton, Michael B Rothberg\",\"doi\":\"10.1101/2024.08.30.24312871\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Background</strong> Guidelines recommend pharmacological venous thromboembolism (VTE) prophylaxis only for high-risk patients, but the probability of VTE considered “high-risk” is not specified. Our objective was to define an appropriate probability threshold (or range) for VTE risk stratification and corresponding prophylaxis in medical inpatients.\",\"PeriodicalId\":501454,\"journal\":{\"name\":\"medRxiv - Health Informatics\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Health Informatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.08.30.24312871\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Health Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.30.24312871","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
What Constitutes High Risk for Venous Thromboembolism? Comparing Approaches to Determining an Appropriate Threshold
Background Guidelines recommend pharmacological venous thromboembolism (VTE) prophylaxis only for high-risk patients, but the probability of VTE considered “high-risk” is not specified. Our objective was to define an appropriate probability threshold (or range) for VTE risk stratification and corresponding prophylaxis in medical inpatients.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
